Related references
Note: Only part of the references are listed.Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy
Maelle Cartel et al.
LEUKEMIA (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance
Wei Zhang et al.
CANCER CELL INTERNATIONAL (2020)
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
Silpa Narayanan et al.
DRUG RESISTANCE UPDATES (2020)
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Haiyang Zhang et al.
MOLECULAR CANCER (2020)
NEK2 induces autophagy-mediated bortezomib resistance by stabilizing Beclin-1 in multiple myeloma
Jiliang Xia et al.
MOLECULAR ONCOLOGY (2020)
N-benzylpiperidinol derivatives as novel USP7 inhibitors: Structure-activity relationships and X-ray crystallographic studies
Minglei Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance
Hao Chen et al.
INVESTIGATIONAL NEW DRUGS (2020)
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism
Nathan J. Schauer et al.
SCIENTIFIC REPORTS (2020)
Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
Si-Min Qi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
Sol-Bi Shin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
USP7: Novel Drug Target in Cancer Therapy
Zhiru Wang et al.
FRONTIERS IN PHARMACOLOGY (2019)
USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis
Yuchong Peng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer et al.
TRENDS IN CELL BIOLOGY (2019)
Discovery and characterization of highly potent and selective allosteric USP7 inhibitors
Gerald Gavory et al.
NATURE CHEMICAL BIOLOGY (2018)
Ubiquitination: Friend and foe in cancer
Mohammed A. Mansour
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma
Reinaldo Franqui-Machin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF-kappa B signaling pathway in multiple myeloma
Yao Yao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis
Dongxue Su et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies
David A. Mahvi et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques
Paola Di Lello et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs
Umberto Malapelle et al.
LUNG CANCER (2017)
USP7 small-molecule inhibitors interfere with ubiquitin binding
Lorna Kategaya et al.
NATURE (2017)
Molecular basis of USP7 inhibition by selective small-molecule inhibitors
Andrew P. Turnbull et al.
NATURE (2017)
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones
Giovanna Carra et al.
ONCOTARGET (2017)
The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells
Francesco Morra et al.
ONCOTARGET (2017)
Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models
Hui Qin Wang et al.
ELIFE (2017)
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7
Ilaria Lamberto et al.
CELL CHEMICAL BIOLOGY (2017)
USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms
Alexandra Pozhidaeva et al.
CELL CHEMICAL BIOLOGY (2017)
USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status
Angelo Agathanggelou et al.
BLOOD (2017)
USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth
Tao An et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors
Chao Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
The PTEN protein: cellular localization and post-translational regulation
Nick R. Leslie et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis
Qian Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis
Ming Ma et al.
ONCOTARGETS AND THERAPY (2016)
Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase
Yu Zhao et al.
EMBO JOURNAL (2015)
Ubiquitin-Specific Protease 7 Accelerates p14ARF Degradation by Deubiquitinating Thyroid Hormone Receptor-Interacting Protein 12 and Promotes Hepatocellular Carcinoma Progression
Jia-Bin Cai et al.
HEPATOLOGY (2015)
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC
Francesco Morra et al.
ONCOTARGET (2015)
ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CH K1
Peijing Zhang et al.
NATURE CELL BIOLOGY (2014)
A 2.2 Å resolution structure of the USP7 catalytic domain in a new space group elaborates upon structural rearrangements resulting from ubiquitin binding
Katrina Molland et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2014)
USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase
S. Giovinazzi et al.
CELL DEATH AND DIFFERENTIATION (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Expression of HAUSP in gliomas correlates with disease progression and survival of patients
Chuandong Cheng et al.
ONCOLOGY REPORTS (2013)
USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis
Y-H Fan et al.
CELL DEATH & DISEASE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
A. Gallardo et al.
BRITISH JOURNAL OF CANCER (2012)
A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
Dharminder Chauhan et al.
CANCER CELL (2012)
Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating Enzyme
Celine Reverdy et al.
CHEMISTRY & BIOLOGY (2012)
Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47
Joseph Weinstock et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Mechanism of USP7/HAUSP Activation by Its C-Terminal Ubiquitin-like Domain and Allosteric Regulation by GMP-Synthetase
Alex C. Faesen et al.
MOLECULAR CELL (2011)
p53 post-translational modification: deregulated in tumorigenesis
Chao Dai et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Frederic Colland et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Targeting ubiquitin specific proteases for drug discovery
Laurent Daviet et al.
BIOCHIMIE (2008)
A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model
Kerstin Becker et al.
CELL CYCLE (2008)
Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: Implications for the regulation of the p53-MDM2 pathway
M Hu et al.
PLOS BIOLOGY (2006)
Share Paper
